<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Targeting Immunosuppression: A Novel Therapeutic Avenue for Polycystic Kidney Disease

Katharina Hopp, PhD | Division of Renal Diseases and Hypertension

minute read

by Department of Medicine | March 17, 2022
Research & Innovation Conference

Department of Medicine Research & Innovation Conference March 17, 2022

Targeting immunosuppression: A novel therapeutic avenue for Polycystic Kidney Disease with Katharina Hopp, PhD, assistant professor, Division of Renal Diseases and Hypertension.

 

Topics: Research